1 week ago
Lord’s Mark and ARKALL Plan Healthcare Expansion Across Caribbean
Lord’s Mark Industries is an Indian healthcare company partnering with ARKALL Holdings in the Caribbean.
They plan to build and operate laboratories that test medical samples.
They also want to sell medical devices, equipment, dialysis machines and other healthcare products.
The project will start in Trinidad & Tobago.
It is expected to expand to all 28 Caribbean countries over three years.
ARKALL will pay for the expansion and help develop the markets.
Lord’s Mark will provide products, training, technical advice and operational support.
The company estimates that the project could produce about US$100 million in export revenue from FY27 to FY31.
It also estimates a potential pathology and diagnostics market worth about US$1.24 billion.
Lord’s Mark Industries and ARKALL Holdings will establish pathology laboratories and commercialise healthcare products across 28 Caribbean countries.
The phased rollout will begin with market assessment and planning in Trinidad & Tobago before expanding over three years.
ARKALL will fund the expansion and lead commercialisation, while Lord’s Mark will supply products and provide technical and operational support.
Lord’s Mark projects approximately US$100 million in export revenue between FY27 and FY31 from the Caribbean rollout.
The company estimates the pathology and diagnostics opportunity across the 28 markets at approximately US$1.24 billion.
- Who
- Lord’s Mark Industries Limited and ARKALL Holdings Limited.
- What
- A strategic collaboration to establish pathology laboratories and commercialise medical devices, equipment and healthcare products across 28 Caribbean countries.
- Where
- The initiative will begin in Trinidad & Tobago and expand across the Caribbean; the announcement was issued from Mumbai, Maharashtra, India.
- When
- Announced August 25; the phased expansion is planned over the next three years, with projected export revenue between FY27 and FY31.
- Why
- To expand access to diagnostics and healthcare technology while creating a regional platform for Lord’s Mark’s exports.
Key facts
- Partners
- Lord’s Mark Industries Limited and ARKALL Holdings Limited
- Initial market
- Trinidad & Tobago
- Planned reach
- All 28 Caribbean countries
- Expansion timeline
- Progressive rollout over three years
- Projected export revenue
- Approximately US$100 million between FY27 and FY31
- Estimated market opportunity
- Approximately US$1.24 billion in pathology and diagnostics across the 28 markets
- Investment responsibility
- ARKALL Holdings Limited will undertake the required expansion investments
Quotes
Senior Management Representative from ARKALL Holdings Limited
Senior management representative of ARKALL Holdings Limited
“The Caribbean presents an important opportunity to strengthen healthcare infrastructure through greater access to quality diagnostics, medical technology and specialised healthcare solutions. Our partnership with Lord’s Mark Industries Limited brings together local market capabilities with an expanding portfolio of healthcare technologies. Beginning with Trinidad & Tobago, our objective is to build a scalable network that can progressively serve healthcare needs across all 28 Caribbean markets.”
republicworld.com
theprint.in
Dr. Sachidanand Upadhyay
Managing Director and CEO of Lord’s Mark Industries Limited
“Our collaboration with ARKALL Holdings Limited marks an important step in taking Lord’s Mark’s healthcare and MedTech capabilities to a wider international market. The Caribbean expansion will allow us to combine our medical technology, pathology and dialysis capabilities with ARKALL’s regional commercial presence. We see this partnership as a long-term platform for expanding our export footprint while contributing to the development of accessible and technology-enabled healthcare infrastructure”
republicworld.com
theprint.in








